1. Home
  2. UTZ vs OMER Comparison

UTZ vs OMER Comparison

Compare UTZ & OMER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Utz Brands Inc

UTZ

Utz Brands Inc

N/A

Current Price

$14.30

Market Cap

1.3B

ML Signal

N/A

Logo Omeros Corporation

OMER

Omeros Corporation

N/A

Current Price

$14.01

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UTZ
OMER
Founded
2018
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
UTZ
OMER
Price
$14.30
$14.01
Analyst Decision
Hold
Buy
Analyst Count
10
3
Target Price
$14.31
★ $27.50
AVG Volume (30 Days)
★ 2.0M
1.0M
Earning Date
11-06-2026
11-16-2026
Dividend Yield
★ 1.77%
N/A
EPS Growth
N/A
★ 98.15
EPS
N/A
★ 0.13
Revenue
★ $1,438,800,000.00
$29,868,000.00
Revenue This Year
$2.07
N/A
Revenue Next Year
$2.29
$66.13
P/E Ratio
★ N/A
$109.15
Revenue Growth
★ 2.09
N/A
52 Week Low
$6.78
$6.70
52 Week High
$14.36
$21.24

Technical Indicators

Market Signals
Indicator
UTZ
OMER
Relative Strength Index (RSI) 53.31 33.31
Support Level $14.20 $9.45
Resistance Level $14.34 $15.32
Average True Range (ATR) 0.03 0.94
MACD -0.00 -0.39
Stochastic Oscillator 40.00 21.09

Price Performance

Historical Comparison
UTZ
OMER

About UTZ Utz Brands Inc

Utz Brands Inc is a manufacturer of branded salty snacks based in the United States. It produces various salty snack foods, including potato chips, tortilla chips, pretzels, cheese snacks, party mixes, pork skins, ready-to-eat popcorn, and other snacks, which include salsa and dips. These products are offered through its flagship brands like Utz, On The Border, Zapp's, and Boulder Canyon, along with other brands, including Golden Flake, Miguelito's, Hawaiian, Bachman, Tim's Cascade, Dirty Potato Chips, TGI Fridays, and Vitner's. The company's products are packaged in a variety of different sizes and configurations, ranging from individual packages to shareable bulk containers. It also sells certain third-party branded products through its distribution network.

About OMER Omeros Corporation

Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. The company's clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (PDE7) inhibitor program.

Share on Social Networks: